Investors CHARM-ed as they take funding past $150m for Cambridge therapeutics company

Retrieved on: 2025-09-03 21:12:34

Tags for this article:

Click the tags to see associated articles and topics

Investors CHARM-ed as they take funding past $150m for Cambridge therapeutics company. View article details on hiswai:

Excerpt

New investors NEA (New Enterprise Associates) and SR One led the round alongside existing backers OrbiMed, F-Prime, NVIDIA and Khosla Ventures.

Article found on: www.businessweekly.co.uk